A detailed history of Forvis Wealth Advisors, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Forvis Wealth Advisors, LLC holds 17,363 shares of DXCM stock, worth $1.39 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
17,363
Previous 16,683 4.08%
Holding current value
$1.39 Million
Previous $1.89 Million 38.5%
% of portfolio
0.03%
Previous 0.05%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$64.0 - $116.06 $43,520 - $78,920
680 Added 4.08%
17,363 $1.16 Million
Q2 2024

Aug 09, 2024

SELL
$110.31 - $140.45 $551 - $702
-5 Reduced 0.03%
16,683 $1.89 Million
Q1 2024

Apr 19, 2024

BUY
$114.22 - $140.1 $35,065 - $43,010
307 Added 1.87%
16,688 $2.31 Million
Q4 2023

Jan 11, 2024

BUY
$75.49 - $124.16 $8,303 - $13,657
110 Added 0.68%
16,381 $2.03 Million
Q3 2023

Oct 25, 2023

SELL
$86.06 - $137.93 $1,463 - $2,344
-17 Reduced 0.1%
16,271 $1.52 Million
Q1 2023

Apr 26, 2023

BUY
$104.0 - $122.92 $208 - $245
2 Added 0.01%
16,288 $1.89 Million
Q4 2022

Feb 02, 2023

BUY
$84.98 - $122.67 $2,124 - $3,066
25 Added 0.15%
16,286 $1.84 Million
Q3 2022

Oct 13, 2022

SELL
$76.35 - $94.18 $5,115 - $6,310
-67 Reduced 0.41%
16,261 $1.31 Million
Q2 2022

Jul 22, 2022

BUY
$67.99 - $132.89 $833,421 - $1.63 Million
12,258 Added 301.18%
16,328 $1.22 Million
Q4 2021

Jan 14, 2022

SELL
$129.87 - $162.82 $129 - $162
-1 Reduced 0.02%
4,070 $2.19 Million
Q3 2021

Oct 14, 2021

BUY
$106.71 - $143.18 $213 - $286
2 Added 0.05%
4,071 $2.23 Million
Q2 2021

Jul 14, 2021

SELL
$80.99 - $107.93 $161 - $215
-2 Reduced 0.05%
4,069 $1.74 Million
Q1 2021

Apr 23, 2021

SELL
$84.79 - $104.74 $13,820 - $17,072
-163 Reduced 3.85%
4,071 $1.46 Million
Q4 2020

Jan 22, 2021

SELL
$78.0 - $104.5 $3,744 - $5,016
-48 Reduced 1.12%
4,234 $1.57 Million
Q3 2020

Nov 05, 2020

BUY
$95.51 - $112.95 $3,056 - $3,614
32 Added 0.75%
4,282 $1.77 Million
Q2 2020

Jul 15, 2020

BUY
$62.68 - $105.34 $2,945 - $4,950
47 Added 1.12%
4,250 $1.72 Million
Q1 2020

Apr 10, 2020

SELL
$47.79 - $75.63 $143 - $226
-3 Reduced 0.07%
4,203 $1.13 Million
Q4 2019

Jan 13, 2020

BUY
$36.62 - $57.29 $2,087 - $3,265
57 Added 1.37%
4,206 $920,000
Q2 2019

Jul 10, 2019

BUY
$27.84 - $38.92 $111 - $155
4 Added 0.1%
4,149 $622,000
Q4 2018

Jan 15, 2019

SELL
$26.99 - $37.37 $512 - $710
-19 Reduced 0.46%
4,145 $497,000
Q2 2018

Jul 13, 2018

SELL
$17.54 - $25.22 $1,140 - $1,639
-65 Reduced 1.54%
4,164 $395,000
Q1 2018

May 25, 2018

BUY
$13.06 - $18.54 $848 - $1,205
65 Added 1.56%
4,229 $314,000
Q1 2018

Apr 20, 2018

BUY
$13.06 - $18.54 $130 - $185
10 Added 0.24%
4,164 $306,000
Q4 2017

Jan 18, 2018

BUY
$11.12 - $15.38 $611 - $845
55 Added 1.34%
4,154 $238,000
Q3 2017

Oct 13, 2017

BUY
$11.36 - $18.98 $46,564 - $77,799
4,099
4,099 $201,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Forvis Wealth Advisors, LLC Portfolio

Follow Forvis Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forvis Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Forvis Wealth Advisors, LLC with notifications on news.